Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats

Behavioural Pharmacology

Volumn 22, Issue 3, 2011, Pages 222-227

  Pechnick, Robert N ^a,b   Manalo, Charlene M ^a   Lacayo, Liliana M ^a   Vit, Jean Philippe ^a   Bholat, Yasmin ^a   Spivak, Inna ^a   Reyes, Kevin C ^a   Farrokhi, Catherine ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acamprosate; addiction; conditioned stimuli; cues; extinction; nicotine; nicotine seeking behavior; rat; reinforcement; reinstatement; self administration

Indexed keywords

ACAMPROSATE; BUPRENORPHINE; NICOTINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; BEHAVIORAL SCIENCE; CONTROLLED STUDY; ILLUMINATION; LIGHT; MALE; NONHUMAN; RAT; REINFORCEMENT; REWARD; TASK PERFORMANCE;

ANIMALS; CUES; DRUG-SEEKING BEHAVIOR; MALE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SELF ADMINISTRATION; TAURINE;

EID: 79955422287     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328345f72c     Document Type: Article

References (35)

1. Bachteler D, Economidou D, Danysz W, Ciccocioppo R, Spanagel R (2005). The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in the rat. Neuropsychopharmacology 30: 1104-1110. (Pubitemid 40720968)
2. Bäckström P, Hyytiä P (2004). Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behaivor. Alcohol Clin Exp Res 28:558-565. (Pubitemid 38506889)
3. Bäckström P, Hyytiä P (2007). Involvement of AMPA/kainite, NMDA, and mGlu5 receptors sin the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology 192:571-580. (Pubitemid 46870751)
4. Benowitz NL (2010). Nicotine addiction. N Engl J Med 362:2295-2303.
5. Bowers MS, Chem BT, Chou JK, Osborne MPH, Gass JT, Bonci A, et al. (2007). Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology 195:397-406. (Pubitemid 350160268)
6. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, et al. (2001). Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515-530. (Pubitemid 34131646)
7. Cohen C, Perrault G, Griebel G, Soubrie P (2005). Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, Rimonanbant (SR141716). Neuropsychopharmacology 30:145-155. (Pubitemid 40024408)
8. Czachowski CL, Legg BH, Samson HH (2001). Effects of acamprosate on ethanol-seeking and self-administration in the rat. Alcohol Clin Exp Res 25:344-350. (Pubitemid 32221813)
9. Donny EC, Caggiula AR, Mielke MM, Jacobs KS, Rose C, Sved AF (1998). Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology 136:83-90. (Pubitemid 28097524)
10. Durbin P, Littleton J, Parot P, Koob G (2005). Pharmacodynamics and pharmacokinetics of acamprosate: an overview. In: Soyka M, editor. Acampro-sate in relapse prevention of alcoholism. Berlin: Springer. pp. 47-674.
11. Epstein DH, Preston KL, Stewart J, Shaham Y (2006). Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 189:1-16. (Pubitemid 44607255)
12. Galici R, Pechnick RN, Poland RE, France CP (2000). Comparison of noncontingent versus contingent cocaine on plasma corticosterone levels in rats. Eur J Pharmacol 387:59-62. (Pubitemid 30035374)
13. Gass JT, Olive MF (2008). Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75:218-265. (Pubitemid 350235390)
14. Grant KA, Wolverton WL (1989). Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals. Pharmacol Biochem Behav 32: 607-611. (Pubitemid 19162376)
15. Jones RT, Benowitz NL (2002). Therapeutics for nicotine addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology. The fifth generation of progress. Philadelphia: Lippincott, Williams & Wilkins. pp. 1533-1543.
16. Katner SN, Magalong JG, Weiss F (1999). Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20:471-479. (Pubitemid 29123874)
17. Kiefer F, Mann K (2010). Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets and individualized therapy. Curr Pharm Des 16:2098-2102.
18. Liu X, Koren AO, Yee S, Pechnick RN, Poland RE, London ED (2003). Self-administration of 5-Iodo-A-85380, a X2 selective nicotinic receptor ligand, by operantly trained rats. Neuroreport 14:1503-1505. (Pubitemid 37083137)
19. Liu X, Caggiula AR, Yee SK, Nobuta H, Poland RE, Pechnick RN (2005). Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. Psychopharmacology 184:417-425.
20. Liu X, Caggiula AR, Yee SK, Nobuta H, Sver AF, Pechnick RN, Poland RE (2007). Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. Neuropsychopharmacology 32:710-718.
21. Mann K, Kiefer F, Spanagel R, Littleton J (2008). Acamprosate: recent findings and future directions. Alcohol Clin Exp Res 32:1105-1110.
22. Mason BJ, Heyser CJ (2010). Acamprosate: a prototype neuromodulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets 9:2098-2102.
23. McNeil JJ, Piccenna L, Ionnides-Demor LL (2010). Smoking cessation - recent advances. Cardiovasc Drugs Ther [Epub ahead of print].
24. MMMR (2009). Cigarette smoking among adults and trends in smoking cessation-United States, 2008. Morb Mort Wkly Rep 58:1227-1232.
25. Paterson NE, Froestl W, Markou A (2005). Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology 30:119-128. (Pubitemid 40024406)
26. Quertemont E, Brabant C, De Witte P (2002). Acamprosate reduced context-specific ethanol effects. Psychopharmacology 164:10-18. (Pubitemid 35203837)
27. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, et al. (2001). The anti-craving compound acamprosate acts as a weak NMDA receptor antagonist, but modulated NMDA receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40:749-760. (Pubitemid 32436452)
28. Schmitz JM, Schneider NG, Jarvik ME (1999). Nicotine. In: Galanter M, Kleber HD, editors. Substance abuse, a comprehensive textbook. 3rd ed. Washington, DC: American Psychiatric Press, Inc. pp. 2763-2294.
29. See RE (2002). Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 71:517-529. (Pubitemid 34117720)
30. See RE, Kruzich PJ, Grimm JW (2001). Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology 154: 301-310. (Pubitemid 32247191)
31. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmaco-logy 168:3-20. (Pubitemid 36851158)
32. Spanagel R, Weiss F (1999). The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521-527. (Pubitemid 29481853)
33. Spanagel R, Sillaber I, Zieglgänsberger W, Corrigall WA, Stewart J, Shaham Y (1998). Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology 139:391-401. (Pubitemid 28435036)
34. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O (2000). Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects of recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA 97:4321-4326. (Pubitemid 30226131)
35. Wilde MI, Wagstaff AJ (1997). Acamprosate: a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 53:1038-1053. (Pubitemid 27254576)